Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patients

Figures & data

Table 1. Patient characteristics.

	Total	Matched comparision
Patients n (%)	155	Stapled 66 (43)	Sutured 89 (57)	p
Median age (years)	71	68	73	0.14
Male, n (%)	112 (73)	52 (79)	60 (68)	0.08
BMI median (Kg/m^2)	25.8	25.5	26.7	0.48
ASA
1	29 (19)	15 (22)	14 (16)
2	78 (50)	36 (55)	42 (47)
≥3	48 (31)	15 (22)	33 (38)	0.14
Neoadjuvant chemotherapy, n (%)	46 (29)	18 (27)	28 (31)	0.35
Pathologic stage, n (%)
≤pT2	88 (57)	36 (55)	52 (58)
>pT2	67 (43)	30 (45)	37 (42)	0.37
Median robot operative time, minutes	295	300	285	0.57
Median estimated blood loss, mL	200	300	150	0.004
Type of urinary diversion, n (%)
Orthotopic neobladder	22 (14)	16 (24)	6 (7)
Ileal conduit	133 (86)	50 (76)	83 (93)	0.002
The median time to first bowel motion (days)	4	4.5	4	0.39
Median hospital stay (days)	11	11	11	0.24

Table 2. Postoperative GIT parameter and complications.

	Total	Stapled	Sutured	p
Low grade Clavien grade
Clavien grade 0	43 (28)	17 (26)	26 (29)
Clavien grade 1	37 (24)	16 (24)	21(24)
Clavien grade 2	47 (30)	18 (27)	29 (33)
High grade Clavien grade
Clavien grade 3a	13 (8)	7 (11)	6 (6)
Clavien grade 3b	12 (8)	7 (10)	5 (6)
Clavien grade 4	2 (1)	1 (2)	1(1)
Clavien grade 5	1 (1)	0 (0)	1 (1)	0.67
Overall 30-d GIT complications, n (%)
No	101 (65)	43 (65)	58 (65)
Yes	54 (35)	23 (35)	31 (35)	1.0
30-d readmission, n (%)	30	22	8
No	125 (81)	45 (68)	80 (90)
Yes	30 (19)	21 (32)	9(10)	0.001
30-d readmission due to GI complication, n (%)	30	22	8
No	146 (94)	60 (91)	86 (97)
Yes	9 (6)	6 (9)	3 (3)	0.17
30-d GI complication type
No complications, n (%)	101 (66)	42 (65)	59 (66)
Paralytic Ileus*, n (%)	30 (20)	12 (19)	18 (20)
Mechanical ileus, n (%)	5 (3)	4 (6)	1 (1)
Diarrhea, n (%)	1 (1)	1 (1)	0
Intractable nausea/vomiting, n (%)	16 (10)	5 (8)	11 (12)	0.58
Median time to first GI complication (d)	4	4	4	0.38

*Ileus is defined as nausea or vomiting, together with abdominal distension requiring cessation of oral intake, possible nasogastric tube placement, and intravenous fluid therapy.